BiotechTube

Cisapride + Placebo

ApprovedTerminated
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Gastroparesis

Conditions

Gastroparesis

Trial Timeline

May 1, 2003 → Nov 1, 2003

NCT ID
NCT01281540

About Cisapride + Placebo

Cisapride + Placebo is a approved stage product being developed by Johnson & Johnson for Gastroparesis. The current trial status is terminated. This product is registered under clinical trial identifier NCT01281540. Target conditions include Gastroparesis.

What happened to similar drugs?

5 of 7 similar drugs in Gastroparesis were approved

Approved (5) Terminated (3) Active (2)
✅tadalafilEli LillyApproved
✅Mosapride + domperidoneSumitomo PharmaApproved
✅Cisapride + PlaceboJohnson & JohnsonApproved
✅TegaserodNovartisApproved
✅Immediate-release omeprazole + Delayed-release omeprazoleBausch HealthApproved
🔄TradipitantVanda PharmaceuticalsPhase 3
🔄Tradipitant + Placebo + Open Label TradipitantVanda PharmaceuticalsPhase 3

Hype Score Breakdown

Clinical
20
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT01286090ApprovedTerminated
NCT01281540ApprovedTerminated

Competing Products

19 competing products in Gastroparesis

See all competitors
ProductCompanyStageHype Score
tadalafil + tadalafil + placeboEli LillyPhase 2
35
GranisetronKyowa KirinPhase 2
27
tadalafilEli LillyApproved
35
Mosapride + domperidoneSumitomo PharmaApproved
39
Cisapride + PlaceboJohnson & JohnsonApproved
35
Naloxegol 25 MG Oral Tablet [Movantik] + Placebo Oral TabletAstraZenecaPhase 2
27
Sitagliptin + PlaceboMerckPhase 1
29
TegaserodNovartisApproved
35
Reglan ODTUCBPre-clinical
26
Hemin + AlbuminRecordatiPhase 2
32
CNSA-001 + PlaceboPTC TherapeuticsPhase 2
32
Immediate-release omeprazole + Delayed-release omeprazoleBausch HealthApproved
37
Velusetrag + PlaceboTheravance BiopharmaPhase 2
29
velusetrag dose 1 + velusetrag dose 2 + velusetrag dose 3 + placeboTheravance BiopharmaPhase 2
29
IW-9179 + Matching PlaceboIronwood PharmaceuticalsPhase 2
29
VLY-686 (Tradipitant)Vanda PharmaceuticalsPhase 2
25
TradipitantVanda PharmaceuticalsPhase 3
37
TradipitantVanda PharmaceuticalsPre-clinical
20
Tradipitant + Placebo + Open Label TradipitantVanda PharmaceuticalsPhase 3
30